In this difficult economic time, companies must be able to diversify and look for new opportunities and target markets. Brazil is a growing country that, despite the financial crisis, continues to grow in a rapid pace. It is important to note that Brazil has the most complex regulations of any country in Latin America.
In this webcast, the speakers will highlight the current status of Brazilian regulatory processes for drug products and discuss how to develop a regulatory strategy using the Brazilian market scenario. The trends in regulatory and clinical requirements as well as marketing and regulatory strategy issues will also be discussed. Regulatory experts Marcela Saad and Adriana Serrão will share their experiences with attendees. This webcast will help attendees who are currently developing applications to submit to the Brazilian authorities as well as those who are planning to diversify themselves to emerging markets.
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
raps@raps.org+1 301 770 2920
JoinMy RAPS DashboardLearn More
About UsTerms of UsePrivacy Policy